Cargando…

Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands

[Image: see text] We report the synthesis and characterization of eight half-sandwich cyclopentadienyl Ir(III) pyridine complexes of the type [(η(5)-Cp(xph))Ir(phpy)Z]PF(6), in which Cp(xph) = C(5)Me(4)C(6)H(5) (tetramethyl(phenyl)cyclopentadienyl), phpy = 2-phenylpyridine as C(∧)N-chelating ligand,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhe, Romero-Canelón, Isolda, Habtemariam, Abraha, Clarkson, Guy J., Sadler, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195516/ https://www.ncbi.nlm.nih.gov/pubmed/25328266 http://dx.doi.org/10.1021/om500644f

Ejemplares similares

Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands
por: Millett, Adam J., et al.
Publicado: (2015)

NMR studies of group 8 metallodrugs: (187)Os-enriched organo-osmium half-sandwich anticancer complex
por: Needham, Russell J., et al.
Publicado: (2021)

New activation mechanism for half-sandwich organometallic anticancer complexes
por: Banerjee, Samya, et al.
Publicado: (2018)

Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity
por: Gatti, Anna, et al.
Publicado: (2018)

Strategies for conjugating iridium(III) anticancer complexes to targeting peptides via copper-free click chemistry
por: Zhang, Wen-Ying, et al.
Publicado: (2019)

The Potent Oxidant Anticancer Activity of Organoiridium Catalysts**
por: Liu, Zhe, et al.
Publicado: (2014)

Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts
por: Chen, Feng, et al.
Publicado: (2018)

Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes
por: Venkatesh, V., et al.
Publicado: (2017)

Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design
por: Soldevila-Barreda, Joan J., et al.
Publicado: (2015)

Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis
por: Hearn, Jessica M., et al.
Publicado: (2013)

Correction to Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis
por: Hearn, Jessica M., et al.
Publicado: (2013)

Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs
por: Shi, Huayun, et al.
Publicado: (2018)

Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes
por: Ma, Wenli, et al.
Publicado: (2019)

In‐Cell Activation of Organo‐Osmium(II) Anticancer Complexes
por: Needham, Russell J., et al.
Publicado: (2016)

Imidazole and Benzimidazole Modified Half-Sandwich Iridium(III) N-Heterocyclic Carbene Complexes: Synthesis, Anticancer Application, and Organelle Targeting
por: Liu, Xicheng, et al.
Publicado: (2020)

Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
por: Romero-Canelón, Isolda, et al.
Publicado: (2015)

Mirror-Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity
por: Fu, Ying, et al.
Publicado: (2013)

Platinum(iv)-azido monocarboxylato complexes are photocytotoxic under irradiation with visible light
por: Shaili, Evyenia, et al.
Publicado: (2021)

Osmium(ii) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells
por: Infante-Tadeo, Sonia, et al.
Publicado: (2021)

Targeting Multiresistant Gram-Positive Bacteria by Ruthenium, Osmium, Iridium and Rhodium Half-Sandwich Type Complexes With Bidentate Monosaccharide Ligands
por: Balázs, Bence, et al.
Publicado: (2022)

Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes
por: Betanzos-Lara, Soledad, et al.
Publicado: (2011)

Os(2)–Os(4) Switch Controls DNA Knotting and Anticancer Activity
por: Fu, Ying, et al.
Publicado: (2016)

De Novo Generation of Singlet Oxygen and Ammine Ligands by Photoactivation of a Platinum Anticancer Complex**
por: Zhao, Yao, et al.
Publicado: (2013)

Photochemical Reactions of Fluorinated Pyridines at Half-Sandwich Rhodium Complexes: Competing Pathways of Reaction
por: Procacci, Barbara, et al.
Publicado: (2013)

Potent anticancer activity of a novel iridium metallodrug via oncosis
por: Ortega-Forte, Enrique, et al.
Publicado: (2022)

Anticancer Activity of Half-Sandwich Ru, Rh and Ir Complexes with Chrysin Derived Ligands: Strong Effect of the Side Chain in the Ligand and Influence of the Metal
por: Rubio, Ana R., et al.
Publicado: (2021)

Halide Control of N,N-Coordination versus N,C-Cyclometalation and Stereospecific Phenyl Ring Deuteration of Osmium(II) p-Cymene Phenylazobenzothiazole Complexes
por: Needham, Russell J., et al.
Publicado: (2017)

Cationic Heteroleptic Cyclometalated Iridium(III) Complexes Containing Phenyl-Triazole and Triazole-Pyridine Clicked Ligands
por: Felici, Marco, et al.
Publicado: (2010)

Cyclometalated iridium(III) chelates—a new exceptional class of the electrochemiluminescent luminophores
por: Kapturkiewicz, Andrzej
Publicado: (2016)

An Unprecedented Family of Luminescent Iridium(III) Complexes Bearing a Six-Membered Chelated Tridentate C^N^C Ligand
por: Hierlinger, Claus, et al.
Publicado: (2017)

An iridium(iii)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent
por: Zhong, Hai-Jing, et al.
Publicado: (2015)

Tailoring the Emission of Fluorinated Bipyridine-Chelated Iridium Complexes
por: Zhang, Guang, et al.
Publicado: (2018)

Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models
por: Kacsir, István, et al.
Publicado: (2022)

Targets, Mechanisms and Cytotoxicity of Half-Sandwich Ir(III) Complexes Are Modulated by Structural Modifications on the Benzazole Ancillary Ligand
por: Acuña, M. Isabel, et al.
Publicado: (2022)

Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468
por: Mondal, Ashaparna, et al.
Publicado: (2022)

Synthesis, Characterisation and In Vitro Anticancer Activity of Catalytically Active Indole-Based Half-Sandwich Complexes
por: Soldevila-Barreda, Joan J., et al.
Publicado: (2020)

Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria
por: Kacsir, István, et al.
Publicado: (2023)

Similarities and differences in d(6) low-spin ruthenium, rhodium and iridium half-sandwich complexes: synthesis, structure, cytotoxicity and interaction with biological targets
por: Gilewska, Agnieszka, et al.
Publicado: (2019)

Experimental and theoretical investigation of cyclometalated phenylpyridine iridium(iii) complex based on flavonol and ibuprofen ligands as potent antioxidant
por: Tabrizi, Leila, et al.
Publicado: (2019)

Elucidation of Charge Contribution in Iridium-Chelated Hydrogen-Bonding Systems
por: Balónová, Barbora, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ne6uulfs6gl877fvf5jdvpbmi